Research Overview

The Cell and Cell Products Fermentation Facility at Waksman Institute has a multi-client base and produces a wide range of bulk biologics including: antimicrobials, cosmetic substrates, flavors/fragrances, biopesticides/bioherbicides and plasmid-derived proteins, enzymes, growth factors and diagnostics to name just a few. We are equipped to handle most requests with the exceptions: pathogenic or opportunistic organisms and mammalian and insect cell lines. The facility is designated BL2-LS. Our bioreactor volumes range from 15 to 800L maximum operating volumes. All projects are conducted under CDA/NDA agreements, which limit discussion of specific company or projects. We operate as a not-for-profit, fee-for-service, self-supportive lab and receive no direct funding from state or federal sources.

MISSION STATEMENT

The primary goal has been to provide affordable fermentation services to a highly diverse client base which includes but not limited to the academia, pharmaceutical and biotech industries. The facility welcomes academia, start-up firms, small research operations, and larger companies who find their in-house facilities overtaxed. The facility meets BL2-LS containment requirements, and is comprised of four contiguous operation units:

Material Preparation Laboratory
Fermentation In-Process/Computer Control
Product Recovery
Analytical Services

With the advantage of having the world\\\'s pharmaceutical industry in its backyard and being situated at a University that offers a diverse set of core facilities and equipment for collaborative use, a productive climate of industrial liaison has been the historical legacy of the facility.

We provide NGS services for research and clinical samples in a CLIP and CAP accredited laboratory.
Our service include consultation, sample processing, sequencing and data analysis , as well as interpretation and reporting